Aptamers Market – Technology Trend Analysis By Applications – Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker Discovery, Research Applications with Market Landscape Analysis – Global Forecasts to 2018

Publisher Name :
Date: 5-Jul-2013
No. of pages: 171
Inquire Before Buying

Aptamers is an emerging market, widely considered as a rival or substitute to antibodies in the scientific industry. It is poised to grow rapidly in various application areas, including therapeutics and diagnostics. The global aptamers market is valued at $287 million in 2013 and is expected to reach $2.1 billion by 2018.

Aptamers existed in parallel with antibodies for two decades, but its market potential was not utilized, even to a fraction of antibodies. However, the achievement of Macugen has given a boost to the aptamer field. The list of promising aptamers in the clinical trials pipeline estimates that these synthetic chemical antibodies will soon surpass monoclonal antibodies in therapeutics, diagnosis, and imaging. With technological merits over antibodies, the aptamers market is poised to grow at par with antibodies in the next 10-15 years.

Though there are just < 60 companies (biotech and pharmaceutical) working on aptamers, there are quite a number of research groups working on diverse applications of aptamers, particularly in studying key target molecules involved in cardiovascular diseases, infectious diseases, and against viral antigens. Hundreds of research articles have been published and a lot of patents granted and filed for this technology.

The aptamers market is analyzed both in terms of qualitative, i.e. technological and quantitative, i.e. revenue, perspectives. The technological analysis includes discussion on inherent characteristics and capabilities of aptamers over antibodies and the various applications where aptamers can find its place. The market revenue analysis includes market segmentation and the expected market position by 2018, with the projected growth rate.

The aptamers market is classified by geography, application segments and aptamer type. The application segments are further divided as therapeutics, diagnostics, biosensors, drug discovery, biomarker discovery, and research applications. The advantages of chemically modified aptamers and low production cost compared to antibodies aid the growth of the market. However, the reduced market acceptance compared to the antibodies and increased time consumption for screening using SELEX will hamper the growth of this market, to a certain extent. While aptamer technology has existed for over two decades, the challenges imposed on the development of aptamers for small molecules has resulted in very few novel aptamers that can bind to practical small molecular targets. Nevertheless, there are many opportunities for the innovative application of small molecule binding aptamers in biosensing, drug discovery, diagnostics and therapeutics.

Besides a discussion on the properties of aptamers in the technological analysis, the basics on nucleic acid aptamers, peptide aptamers and the SELEX method for their synthesis are also discussed. Research applications are specifically discussed regarding aptamers use in flow cytometry, reagents and assays, mass spectrometry and western blotting. In addition, a number of therapeutic targets that are validated by basic research have been displayed under the therapeutics application segment. The complete value chain of the aptamers market is schematically represented and the significance of each stakeholder has been briefed.

Apart from the technological and market analysis, the investor climate has been assessed by tracking the complete investor network and collecting data on funds/grants and investments made towards the aptamers. Insights on current and future technological investment trends have also been discussed.

The adoption and developmental potential of the aptamers technology market has been discussed on a geographic basis, i.e. North America, Europe, Asia-Pacific, and Rest of the world, by taking select countries that are poised to have a greater market value during the forecast period.

In brief, this research report provides:

  • A detailed description of the global technology developments and evolving trends in the aptamers field with key prominence on research innovations, collaborative efforts, and investments for aptamers.
  • A close view on the aptamer based drug development for treatment of specific diseases by providing details and status of current aptamer drugs in pipeline.
  • An impact analysis of major drivers and restraints influencing the adoption and growth of the aptamers market during the period of 2013to 2018.
  • Porters five forces analysis and SWOT analysis.
  • Market size – global market forecast for 2013-2018, including demand side analysis and strategic recommendations for technology/product developers.
  • Competitive landscape based on the analysis of key patents and research publications.

Scope of the Report

This research report categorizes the global aptamers market into geography, applications, and aptamer type. The applications market is further broken down by geography, with exhaustive revenue analysis for 2012 and 2013, as well as the forecast up to 2018.

Global Aptamers Market – By Application

  • Therapeutics
  • Diagnostics
  • Biosensors
  • Drug discovery
  • Biomarker discovery
  • Research applications

Global Aptamers Market – By Aptamer Type

  • Nucleic acid aptamers
  • Peptide aptamers

Global Aptamers Market – By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW)

Aptamers Market – Technology Trend Analysis By Applications – Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker Discovery, Research Applications with Market Landscape Analysis – Global Forecasts to 2018

Table Of Contents

1 Introduction
1.1 Logical Assumptions In This Study Based On Reliable Sources
1.2 Key Take-Aways
1.3 Report Scope
1.4 Research Methodology
1.5 Key Data Points From Secondary And Primary Sources

2 Executive Summary

3 Aptamers – Technology Landscape Analysis
3.1 Technology Overview
3.2 History & Milestones Of Aptamers
3.3 Aptamers Vs Antibodies
3.4 Aptamer Types
3.4.1 Nucleic Acid Aptamers
3.4.2 Peptide Aptamers
3.5 Aptamer Synthesis & Modifications
3.6 Applications
3.6.1 Therapeutics
3.6.1.1 Different Targets Of Therapeutic Interest
3.6.2 Diagnostics
3.6.3 Biosensors
3.6.4 Drug Discovery
3.6.5 Biomarker Discovery
3.6.6 Research Applications
3.6.6.1 Reagents & Assays
3.6.6.2 Flow Cytometry
3.6.6.3 Mass Spectrometry
3.6.6.4 Western Blotting
3.7 Technology Value Chain Analysis
3.8 Aptamers – Technology Innovations And Products With Applications

4 Aptamers – Market Landscape Analysis
4.1 Aptamers Market Segmentation
4.2 Aptamers Technology - Global Impact
4.3 Market Forecast (2013 - 2018) – Overview
4.4 Global Aptamers Market Revenue Forecast (2013-2018)
4.4.1 Global Aptamers Market Revenue – By Geography
4.4.1.1 North America
4.4.1.2 Europe
4.4.1.3 Asia Pacific
4.4.1.4 Rest Of The World
4.4.2 Global Aptamers Market Share – By Geography
4.4.2.1 North America
4.4.2.2 Europe
4.4.2.3 Asia Pacific
4.4.2.4 Rest Of The World
4.4.3 Global Aptamers Market Revenue – By Application Segments
4.4.3.1 Global Aptamers Market Share – By Segments
4.4.3.2 Therapeutic Aptamers Market – By Region
4.4.3.3 Diagnostics Aptamers Market – By Region
4.4.3.4 Biosensors Aptamers Market – By Region
4.4.3.5 Drug Discovery Aptamers Market – By Region
4.4.3.6 Aptamers Biomarker Discovery Market – By Region
4.4.3.7 Aptamers Research Applications Market – By Region
4.4.4 Global Aptamers Market Revenue – By Aptamer Type
4.4.4.1 Nucleic Acid Aptamer Market – By Region
4.4.4.2 Peptide Aptamer Market – By Region
4.4.4.3 Nucleic Acid And Peptide Aptamers Market Share – By Region
4.5 Market Dynamics
4.5.1 Drivers - Explanation
4.5.1.1 Impact Analysis By Timeline
4.5.2 Restraints – Explanation
4.5.2.1 Impact Analysis By Timeline
4.6 SWOT Analysis
4.7 Porter’s Five Forces Analysis

5 Technology Investment Potential
5.1 Investment Climate Assessment
5.2 Investor Network
5.3 Some Funds And Investments On Aptamers
5.4 Some Funds And Investments From Nih – By Fiscal Year
5.5 Some Funds And Investments From Nih – By Its Associated Institutes/Centers (FY 2008-2013)
5.6 Insights On Current And Future Tech-Investment Trends

6 Aptamers – Technology Adoption And Development Potential
6.1 Geographic Adoption And Development Potential - Overview
6.2 North America
6.3 Europe
6.4 Asia-Pacific
6.5 Row – Selected Countries
6.6 Demand Side Analysis
6.7 Technology Roadmap

7 Aptamers Competitive Landscape
7.1 Competitive Landscape Analysis
7.2 Key Acquisitions/Partnerships/Agreements/Collaborations (2009 – 2013)
7.3 Startups And Spinoff’s Based On Aptamers Technology
7.4 Clinical Trials Of Aptamers – By Different Properties (Anti-Coagulant Aptamers, Anti-Angiogenic Aptamers, Anti-Oncogenic Aptamers, Anti-Diabetic Aptamers)
7.4.1 Apamer Based Drugs In Clinical Trials

8 Intellectual Property And Research Strength Analysis
8.1 Selected Aptamer And Selex Patents
8.2 IP Strength Analysis Of Aptamers
8.3 Proprietary Technologies Based On Aptamers

9 Analyst Insights And Recommendations
9.1 Analyst Insights
9.2 Strategic Recommendations For Technology & Business Investors
9.3 Open Opportunity Invitations In The Field For Business Development

10 Company Profiles
10.1 AM Biotechnologies, Llc
10.2 Aptagen, LIC
10.3 Aptamer Sciences Inc.
10.4 Aptamer Solutions Ltd
10.5 Aptares AG
10.6 Base Pair Biotechnologies
10.7 Integrated Dna Technologies, Inc
10.8 Neoventures Biotechnology Inc.
10.9 NOXXON Pharma AG
10.10 OTC Biotech
10.11 Somalogic, Inc.
10.12 Trilink Biotechnologies, Inc.
10.13 Vivonics
10.14 Pfizer
10.15 Aptamatrix, Inc.
10.16 Aptusbiotech
10.17 Bioapter S.L.
10.18 Cd Genomics
10.19 Lucerna, Inc.
10.20 Ophthotech Corporation
10.21 Regado Biosciences, Inc.

List Of Tables

Tab - 1 Global Aptamers Market, 2013 - 2018 ($Million)
Tab - 2 Global Aptamers Market, By Geography, 2013 - 2018 ($Million)
Tab - 3 Global Aptamers Market Revenue, By Application Segment, 2013 - 2018 ($Million)
Tab - 4 Therapeutic Aptamers Market, By Geography, 2013 - 2018 ($Million)
Tab - 5 Diagnostics Aptamers Market, By Region, 2013 - 2018 ($Million)
Tab - 6 Biosensor Aptamers Market, By Geography, 2013 - 2018 ($Million)
Tab - 7 Drug Discovery Aptamers Market, By Geography, 2013 - 2018 ($Million)
Tab - 8 Aptamers Biomarker Discovery Market, By Geography, 2013 - 2018 ($Million)
Tab - 9 Aptamers Research Applications Market, By Geography, 2013 - 2018 ($Million)
Tab - 10 Global Aptamers Market, By Type, 2013 - 2018 ($Million)
Tab - 11 Nucleic Acid Aptamers Market, By Geography, 2013 - 2018 ($Million)
Tab - 12 Peptide Aptamers Market, By Geography, 2013 - 2018 ($Million)
Tab - 13 Funds By Nih & Associated Centers 2008-2013 ($Million)
Tab - 14 Projects And Funds By Nih & Associated Centers 2008-2013 ($Million)

List Of Figures

Fig - 1 Global Market Of Aptamers 2013 – 2018 ($Million)
Fig - 2 Global Market Of Aptamers 2013 – 2018 ($Million)
Fig - 3 Global Aptamers Market Revenue, By Geography, 2013 – 2018 ($Million)
Fig - 4 Global Aptamers Market Share By Geography, 2013
Fig - 5 Global Aptamers Market Share By Geography, 2018
Fig - 6 Global Aptamers Technology Market Revenue, By Applications, 2013 – 2018 ($Million)
Fig - 7 Global Aptamers Technology Market Share, By Applications, 2013 – 2018
Fig - 8 Global Aptamers Market Share By Segments, 2013
Fig - 9 Global Aptamers Market Share By Segments, 2018
Fig - 10 Therapeutic Aptamers Market, By Region, 2013 – 2018 ($Million)
Fig - 11 Therapeutic Aptamer Market By Region, 2013
Fig - 12 Therapeutic Aptamer Market By Region, 2018
Fig - 13 Diagnostics Aptamers Market, By Region, 2013 – 2018 ($Million)
Fig - 14 Diagnostics Aptamers Market By Region, 2013
Fig - 15 Diagnostics Aptamers Market By Region, 2018
Fig - 16 Biosensor Aptamers Market, By Region, 2013 – 2018 ($Million)
Fig - 17 Biosensor Aptamers Market By Region, 2013
Fig - 18 Biosensor Aptamers Market By Region, 2018
Fig - 19 Drug Discovery Aptamers Market, By Region, 2013 – 2018 ($Million)
Fig - 20 Drug Discovery Aptamers Market By Region, 201380
Fig - 21 Drug Discovery Aptamers Market By Region, 201880
Fig - 22 Aptamers Biomarker Discovery Market, By Region, 2013 – 2018 ($Million)
Fig - 23 Aptamers Biomarker Discovery Market By Region, 2013
Fig - 24 Aptamers Biomarker Discovery Market By Region, 2018
Fig - 25 Aptamers Research Applications Market, By Region, 2013 – 2018 ($Million)
Fig - 26 Aptamers Research Applications Market By Region, 2013
Fig - 27 Aptamers Research Applications Market By Region, 2018
Fig - 28 Global Aptamers Market, Nucleic Acid Aptamer, 2013 – 2018 ($Million)
Fig – 29 Global Aptamers Market, Peptide Aptamer, 2013 – 2018 ($Million)

  • Water Treatment Chemicals Market to be driven by Increasing Demand from Developing Economies
    The global market for water treatment chemicals is growing at a steady pace with rapid urbanization and high demand from end-users. Water treatment chemicals are used for treating municipal water as well as agricultural wastewater. With higher demand for clean, drinking water with increasing population and increase in the number of industries, the global market [...]
  • Rise in Prevalence of Allergic Diseases Driving the Global Allergy Diagnostics Market
    With rise in the incidences of allergic diseases in the world, the global allergy diagnostics market has also witnessed steady growth. In recent years, there has been an increase in the number of people suffering from different allergies, particularly food allergies and drug allergies. The number of people suffering from asthma has also increased in [...]
  • Global Video Surveillance Market Driven by Increasing Demand for Security
    The global market for video surveillance has been witnessing steady growth with increase in demand for advanced surveillance systems by different law enforcement agencies. Increase in adoption of video surveillance by different sectors such as banking and finance, healthcare, transportation, and retail is one of the major drivers in the market. In 2013, the global [...]
  • Global Empty Capsules Market Driven by Growth in Pharmaceutical Industry
    With rapid growth in the pharmaceutical industry, the market for empty capsules has also grown at a steady pace. Some of the factors which are driving the growth of the empty capsules market are rise in aging population which is increasing the demand for capsule based drugs, technological advancement and increase in demand from the [...]
  • Global Aramid Fiber Industry to Witness High Growth in the Future
    With increasing use of aramid fibers in various industries, the global market for aramid fibers has grown significantly in recent years. Aramid fibers have a number of properties such as low density, heat resistance, high tensile strength, abrasion resistance, chemical resistance and impact resistance.  Asia-Pacific is the largest market for aramid fibers, followed by North [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Plasma Fractionation Market by Product (Albumin, Immunoglobulin, Factor VIII, Protease Inhibitors), Application (Neurology, Immunology, Hematology, Critical Care) & by End-user (Hospitals, Clinical Research Laboratories) – Global Forecast to 2019
    Published: 16-Dec-2014        Price: US $4650 Onwards        Pages: 200
    Over the last five years, the plasma fractionation market witnessed tremendous growth, primarily due to the growth in aging population, increasing number of hemophilic patients, rising use of IVIg, and high prevalence of chronic disorders across the globe. In this report, the global plasma fractionation market is divided on the basis of product, application, and end user. Based on type of products, the plasma fractionation market is mainly segmented into albumin, immunoglobulins, coagulation ......
  • Preparative and Process Chromatography Market by Instruments (Liquid & Gas, HPLC, Flash), Consumables (Columns, Solvents, Buffers, Valves, Gauges, Seals), Accessories, Service, End User (Biotechnology, Pharmaceutical, Food & Agriculture) – Forecasts to 2019
    Published: 10-Dec-2014        Price: US $4650 Onwards        Pages: 250
    The preparative and process chromatography market is expected to reach $8,950 million by 2019 from $6351.5 million in 2014, at a CAGR of 7.1%. The global Preparative and Process Chromatography market is categorized on the basis of products and services, end user, and geography. The service segment is expected to register the highest growth rate in the Preparative and Process Chromatography market, by products and services, during the forecast period. This favorable growth is attributed to increa......
  • biOasis Technologies Inc. – Product Pipeline Review – 2014
    Published: 10-Dec-2014        Price: US $1500 Onwards        Pages: 26
    Global Markets Direct's, ‘biOasis Technologies Inc. Product Pipeline Review 2014', provides an overview of the biOasis Technologies Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of biOasis Technologies Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also rev......
  • Can-Fite BioPharma Ltd. – Product Pipeline Review – 2014
    Published: 10-Dec-2014        Price: US $1500 Onwards        Pages: 35
    Global Markets Direct's, ‘Can-Fite BioPharma Ltd. Product Pipeline Review 2014', provides an overview of the Can-Fite BioPharma Ltd.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Can-Fite BioPharma Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews l......
  • Global Bio-detection Market 2014-2018
    Published: 10-Dec-2014        Price: US $2500 Onwards        Pages: 67
    Bio-detection has emerged as a solution to the public and governments. With an increase in bio-terrorism, the occurrence of illness and deaths is very frequent. This event is caused by the airborne chemicals or pathogens that are released by a terrorist or a group of people or even by an individual for a motive. These pathogens can be detected by a system called bio-detection, which signals the entry or the existence of a virus. The increasing attacks have brought a major concern to the public a......
  • Adienne Pharma & Biotech – Product Pipeline Review – 2014
    Published: 10-Dec-2014        Price: US $1500 Onwards        Pages: 20
    Global Markets Direct's, ‘Adienne Pharma & Biotech Product Pipeline Review 2014', provides an overview of the Adienne Pharma & Biotech's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Adienne Pharma & Biotech's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It......
  • RegeneRx Biopharmaceuticals, Inc. – Product Pipeline Review – 2014
    Published: 10-Dec-2014        Price: US $1500 Onwards        Pages: 28
    Global Markets Direct's, ‘RegeneRx Biopharmaceuticals, Inc. Product Pipeline Review 2014', provides an overview of the RegeneRx Biopharmaceuticals, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of RegeneRx Biopharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and mo......
  • BioApex, s.r.o. – Product Pipeline Review – 2014
    Published: 10-Dec-2014        Price: US $1500 Onwards        Pages: 19
    Global Markets Direct's, ‘BioApex, s.r.o. Product Pipeline Review 2014', provides an overview of the BioApex, s.r.o.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of BioApex, s.r.o.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featu......
  • Cerecor Inc. – Product Pipeline Review – 2014
    Published: 10-Dec-2014        Price: US $1500 Onwards        Pages: 25
    Global Markets Direct's, ‘Cerecor Inc. Product Pipeline Review 2014', provides an overview of the Cerecor Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Cerecor Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs